ZBIO Competitors & Alternatives
Compare Zenas BioPharma, Inc. Common Stock with similar stocks in the same industry
Biotechnology
ZBIO
Main Stock$27.64
-1.32%
Tradestie Score
53
Market Cap
$931.48M
Revenue Growth
-100.0%
Analyst Upside
+73.2%
Supply-Chain & Ecosystem Map (Customers, Suppliers & Direct Competitors)
Bottleneck Score: 2/10
Drug Discovery Biotech
Drug Design
Top Competitors
215 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
COGT
Cogent Biosciences, Inc. Common Stock
|
$27.64
-3.22%
|
$1.97B | - | 39 | Compare |
|
OCUL
Ocular Therapeutix, Inc.
|
$5.99
-3.62%
|
$1.92B | - | 45 | Compare |
|
CELC
Celcuity Inc. Common Stock
|
$61.31
-4.75%
|
$1.92B | - | 33 | Compare |
|
LQDA
Liquidia Corporation Common Stock
|
$56.82
-1.03%
|
$1.90B | - | 30 | Compare |
|
VERA
Vera Therapeutics, Inc. Class A Common Stock
|
$27.26
-2.99%
|
$1.84B | - | 46 | Compare |
|
IMCR
Immunocore Holdings plc American Depositary Shares
|
$29.08
-2.89%
|
$1.81B | - | 47 | Compare |
|
ABCL
AbCellera Biologics Inc. Common Shares
|
$11.14
-3.08%
|
$1.78B | - | 62 | Compare |
|
DYN
Dyne Therapeutics, Inc. Common Stock
|
$16.70
-2.71%
|
$1.78B | - | 51 | Compare |
|
TWST
Twist Bioscience Corporation Common Stock
|
$105.61
-5.37%
|
$1.77B | - | 52 | Compare |
|
VRDN
Viridian Therapeutics, Inc. Common Stock
|
$30.37
-1.64%
|
$1.74B | - | 37 | Compare |
More ZBIO Analysis
Data updated: Nov 16, 2026 | Industry: Biotechnology (SIC 2834)
215 stocks in this industry